This study focuses on acute pneumonia in elderly patients. The research examines whether acetylsalicylic acid (commonly known as aspirin) can help reduce deaths from any cause in elderly patients with pneumonia. The study will compare aspirin treatment to placebo in patients who are hospitalized with pneumonia symptoms.
The treatment involves giving patients either aspirin or placebo. The aspirin will be given in different forms: as a gastro-resistant tablet, as an intravenous solution, or with sodium chloride solution. The medication or placebo will be given over a period of 90 days while monitoring the patient’s condition.
The study will track how many patients survive and what complications they experience, particularly focusing on heart and blood vessel-related problems. Researchers will also monitor for any bleeding that might occur as a side effect of the treatment. The study will follow patients for up to 120 days to understand both the benefits and risks of using aspirin in elderly pneumonia patients.



France